Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Today 4:24 EDT
Tags
Biotechnology
Health & Science
Pfizer Inc
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
Eli Lilly and Co
Health care industry
AstraZeneca PLC
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Pharmaceuticals
Business
Companies
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Eli Lilly and Co
Health care industry
Healthy Returns
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Healthy Returns
Eli Lilly and Co
Health care industry
From
CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
Tags
Markets
Novo Nordisk A/S
Europe News
From
CNBC.com News
CNBC Daily Open: Everyone's waiting for Nvidia
August 28, 2024
Tags
Censorship
Stock markets
Marvell Technology Inc
From
CNBC.com News
CNBC Daily Open: Stocks up ahead of Nvidia earnings
August 27, 2024
Tags
Advanced Micro Devices Inc
Nordstrom Inc
Meta Platforms Inc
From
CNBC.com News
5 things to know before the stock market opens Tuesday
August 27, 2024
Tags
Entertainment
Business
5 Things to Know
From
CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
Tags
Business
Pharmaceuticals
Business News
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
Tags
Eli Lilly and Co
Aflac Inc
Equity Residential
From
CNBC.com News
CNBC Daily Open: A 'crazy' summer
August 21, 2024
Tags
JD/Com Inc
Asia Economy
Intellectual property
From
CNBC.com News
CNBC Daily Open: 'Crazy' summer
August 20, 2024
Tags
Retail sales
Levi Strauss & Co
Stock markets
From
CNBC.com News
Wednesday's big stock stories: What's likely to move the market in the next trading session
August 20, 2024
Tags
Investing
PRO: Playbooks
Target Corp
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Bristol/Myers Squibb Co
Merck & Co Inc
Amgen Inc
From
CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
August 14, 2024
Tags
Target Corp
Aecon Group Inc
Walmart Inc
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Health & Science
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
Breaking news
Pharmaceuticals
Business
From
CNBC.com News
After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends
August 08, 2024
Tags
U/S/ Markets
Business News
Markets
From
CNBC.com News
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
August 08, 2024
Tags
Biotech and Pharmaceuticals
Earnings
Eli Lilly and Co
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
August 07, 2024
Tags
Ulta Beauty Inc
Capri Holdings Ltd
ETSY Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
August 05, 2024
Tags
Eli Lilly and Co
Apple Inc
Technology
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Augmedix Inc
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Biogen Inc
Biotechnology
US: News
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.